Becker's Healthcare January 9, 2025
Personalized health navigation company Transcarent is planning to purchase health benefits navigator Accolade for $621 million.
Transcarent plans to acquire Accolade for $7.03 per share in cash in the second quarter of 2025, according to a Jan. 8 news release.
The deal is being financed by General Catalyst and Glen Tullman’s 62 Ventures....